Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma have?
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma has 2,479 citations in the OpenAlex counts ScholarIQ stores.
When was Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma published?
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma has 2021 year in the ScholarIQ index.
What is the open-access status of Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma?
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma?
The DOI for Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma is on the source record.
What is the PMID of Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma?
The PMID for Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma is on the source record.
What is the OpenAlex record for Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma?
The OpenAlex for Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma is on the source record.